High performance liquid chromatography method for determination of methyl-5-benzoyl-2-benzimidazole carbamate (mebendazole) and its main degradation product in pharmaceutical dosage forms

被引:58
作者
Al-Kurdi, Z
Al-Jallad, T
Badwan, A
Jaber, AMY [1 ]
机构
[1] King Fahd Univ Petr & Minerals, Dept Chem, Dharwad 31261, Karnataka, India
[2] Jordanian Pharmaceut Mfg & med Equipment Co Ltd, Naor 11710, Jordan
关键词
mebendazole; HPLC; degradation; pharmaceutical dosage forms;
D O I
10.1016/S0039-9140(99)00212-X
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Methyl-5-benzoyl-2-benzimidazole carbamate (mebendazole) is a drug used as an anthelmintic. A high performance liquid chromatography method has been developed in this study to determine mebendazole and its degradation product in the pharmaceutical dosage forms (tablets and suspension). The expected major degradation product of mebendazole in the dosage forms has been prepared, and identified as 2-amino-5-benzoylbenzimidazole. The proposed HPLC assay was found to be selective, accurate (% recoveries were in the range of 99.9-100.9) for both, mebendazole and the degradation product, repeatable and reproducible (replicate measurements for short and long term measurements showed % RSD of less than or equal to 1.4). The methodology could be considered as a stability indicating method for mebendazole in pharmaceutical dosage forms. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1089 / 1097
页数:9
相关论文
共 23 条
[1]   DETERMINATION OF MEBENDAZOLE AND ITS FORMULATIONS USING H-1 NUCLEAR MAGNETIC-RESONANCE SPECTROMETRY [J].
ALKHAMEES, HA ;
ELSHAZLY, BEM .
ANALYST, 1988, 113 (04) :599-602
[2]   2 HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATIONS FOR MEBENDAZOLE AND ITS METABOLITES IN HUMAN-PLASMA USING A RAPID SEP PAK C18 EXTRACTION [J].
ALLAN, RJ ;
GOODMAN, HT ;
WATSON, TR .
JOURNAL OF CHROMATOGRAPHY, 1980, 183 (03) :311-319
[3]  
BAEYENS W, 1986, PHARMAZIE, V41, P636
[4]   FLUOROMETRIC ANALYSIS OF MEBENDAZOLE AND FLUBENDAZOLE WITH HYDROGEN-PEROXIDE [J].
BAEYENS, W ;
FATTAH, FA ;
DEMOERLOOSE, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1985, 3 (05) :397-404
[5]   LOW-TEMPERATURE PHOSPHORESCENCE ANALYSIS OF MEBENDAZOLE AND RELATED IMIDAZOLES [J].
BAEYENS, WRG ;
FATTAH, FA ;
DEMOERLOOSE, P .
ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS, 1985, 18 (17) :2105-2126
[6]   APPLICATION OF A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY COULOMETRIC METHOD FOR THE ESTIMATION OF MEBENDAZOLE AND ITS METABOLITES IN HUMAN SERA [J].
BETTO, P ;
GIANBENEDETTI, M ;
PONTI, F ;
FERRETTI, R ;
SETTIMJ, G ;
GARGIULO, M ;
LORENZINI, R .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 563 (01) :115-123
[7]   CLINICAL PHARMACOKINETICS OF HIGH-DOSE MEBENDAZOLE IN PATIENTS TREATED FOR CYSTIC HYDATID-DISEASE [J].
BRAITHWAITE, PA ;
ROBERTS, MS ;
ALLAN, RJ ;
WATSON, TR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (02) :161-169
[8]  
*COUNC EUR, 1997, EUR PHARM, P1151
[9]  
HIMMELREICH M, 1997, AUST J PHARM SCI, V5, P125
[10]  
IOSIFIDOU EG, 1997, DRUG METAB DISPOS, V25, P327